Xiaodan Xu

28 Fuxing Road
Haidian, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Pharmacokinetics and Dosimetry of 177Lu-DOTATATE in Patients with Advanced Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial.

Pharmacokinetics and Dosimetry of 177Lu-DOTATATE in Patients with Advanced Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial.

Journal: Molecular pharmaceutics

Published: June 05, 2026

Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors.

Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors.

Journal: EJNMMI reports

Published: January 07, 2026

Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study.

Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study.

Journal: CNS neuroscience & therapeutics

Published: January 07, 2026

[18F] PSMA-3Q PET/CT radiomics at 45% SUVmax threshold: predicting post-surgical ISUP grade ≥ 4 and extraprostatic extension for noninvasive stratification in prostate cancer management.

[18F] PSMA-3Q PET/CT radiomics at 45% SUVmax threshold: predicting post-surgical ISUP grade ≥ 4 and extraprostatic extension for noninvasive stratification in prostate cancer management.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: December 09, 2025

Head-to-Head comparison of [18F]AlF-NOTA-TATE and [68Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors: a prospective study.

Head-to-Head comparison of [18F]AlF-NOTA-TATE and [68Ga]Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors: a prospective study.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 27, 2025

[Retracted] lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection.

[Retracted] lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection.

Journal: Oncology letters

Published: May 15, 2025

Monitoring Sorafenib Resistance and Efficacy in Hepatocellular Carcinoma Using [18F]Alfatide II and [18F]Fluorodeoxyglucose Positron Emission Tomography.

Monitoring Sorafenib Resistance and Efficacy in Hepatocellular Carcinoma Using [18F]Alfatide II and [18F]Fluorodeoxyglucose Positron Emission Tomography.

Journal: Molecular pharmaceutics

Published: February 24, 2025

Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

Comparison of 64Cu-DOTA-PSMA-3Q and 64Cu-NOTA-PSMA-3Q utilizing NOTA and DOTA as bifunctional chelators in prostate cancer: preclinical assessment and preliminary clinical PET/CT imaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 20, 2024

Preclinical Study of a Dual-Target Molecular Probe Labeled with 68Ga Targeting SSTR2 and FAP.

Preclinical Study of a Dual-Target Molecular Probe Labeled with 68Ga Targeting SSTR2 and FAP.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 17, 2024

Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer's disease.

Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: September 05, 2024

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study.

Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [64Cu] Cu-DOTA-PSMA-3Q: a pilot preclinical study.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 30, 2024

The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma.

The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma.

Journal: EJNMMI research

Published: August 29, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026